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ABSTRACT: Dose distribution (depthwise and laterally) to organs outside the radiother-
apy treatment field can be significant and therefore is of clinical interest from the radiation
protection point of view. In the present work, measurements were performed in a locally
fabricated polystyrene phantom using TLD chips (LiF-100) for different teletherapy units
(60Co gamma ray, 120 kVp X-ray and 250 kVp X-ray) to estimate the dose distribution at
distances up to 40 cm from the field edge along the central axes of the field size. Finally,
the dose distribution for 60Co beam energy is parameterized as a function of depth, distance
from field edge, and field size and shape.
Key words: Radiotherapy treatment field, Dosimetry assessment.
PACS : 87; 87.55.N-, 87.53.Bn.
Shortened version of the title:
A DOSIMETRY ASSESSMENT IN CASE OF RADIOTHERAPY TREATMENT
1 INTRODUCTION
In radiotherapy treatment, however, comparatively large exposure dose from X-rays or gamma
rays is used in the treatment of cancer patients which not only kills the cancerous or malig-
nant tissues but also, unfortunately, causes radiation exposure to surrounding healthy tissue
and other critical organs like central nervous system, haemopoietic system, eye lens, gonad
etc. The chance of a second cancer occurring following radiotherapy for a variety of cancers
among long-term survivors is also well-known. In the United Nations report on the effects of
atomic radiation (UNSCEAR, 1977) it is estimated that exposure of one million persons to
one rad each of ionizing radiation will induce about 20 leukaemias and 100 fatal cancers of
other sites. From the radiation protection point of view, one of the basic principle of using
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ionizing radiation in medical fields (Benson, 1990) is that the dose to surrounding tissues
should be minimized by using the best available treatment planning and by taking measures
to reduce the dose as far as possible to other parts of the body. Treatment planning should
be extended to regions outside the immediate vicinity of the target volume, thus enabling
calculation of radiation doses to other organs and tissues, which are adjacent to the treatment
area for the purpose of estimating risk of complications.
The physical part of treatment planning for external beam radiation therapy involves use
of information on dose distribution. Information for treatment planning, including data on
depth doses and dose distributions, as supplied by the equipment manufacturer, should not
be used clinically without independent confirmation of the actual values (ICRP publication
44, 1985). It is thus, necessary to measure dose to different parts of the human body due to
various radiotherapy procedures performed over cancer patients. Several studies were per-
formed to measure the radiation dose outside the primary beam for square or rectangular
fields, by applying different methods in many hospitals (Ahmed et al., 1999; Brandan et al.,
1994; Francois et al., 1988; Green et al., 1983; Green et al., 1985; Kase et al., 1983; Ahmed,
1994; Miah et al., 1998; Sherazi et al., 1985; Starkeschall et al., 1983; Ahmed, M.F. 2000).
In a developing country like Bangladesh, we do not have sufficient data about the dose dis-
tribution over different organs of the body in different radiotherapy procedures which might
give an idea about the existing situation in the country that might help take steps against
hazardous effects (Ahmed et al., 1999). Therefore, the main objective of the present study is
to determine the dose distribution over a phantom in the case of radiotherapy treatment of
cancer patients. The overall measurements were conducted at square and rectangular fields,
which are usually used in treatment of cancer patients throughout Bangladesh. Therefore,
the measurements were performed in the context of Bangladesh to determine the depth factor
(DF), and Elongation Factor (EF) over a polystyrene phantom in the 60Co teletherapy unit
at the Delta Medical Center Limited, Dhaka, Bangladesh and Deep therapy X-ray unit at
the Radiotherapy Department, Dhaka Medical College Hospital, Dhaka, Bangladesh. The
Thermoluminescent Dosimeter (TLD) chips (TLD-100) were employed for the determination
of dose. The measured data would be useful to recommend measures for the protection of
other organs of cancer patients undergoing radiotherapy, which is one of the major objective
in radiological practice.
2 INSTRUMENTATION, MATERIAL AND METHOD
2.1 TLD System
In the present study, Lithium Fluoride (LiF) with impurity doping in the form of chips having
commercial names of TLD-100 (natural isotopes with ratio of 7.5% 6Li and 92.5% 7Li and
of size 1/8 inch × 1/8 inch × 0.035 inch and weighing about 24 mg) have been used as TL
dosimeters and the chips were supplied by the Harshaw Chemical Company, Cleveland, Ohio,
USA. The TLD chips were read with the help of Harshaw TLD system, Model 3500 manual
TLD reader. This TLD system is shown in Fig. 1(a). The grouping of the chips under study
were done using irradiator of a 90Sr/90Y source (Model 2210, Nominal Activity: 33 MBq
(0.917 mCi, 18 November 1998), which was calibrated by Bicron Technologies. The averaged
137Cs equivalent dose was found to be 6.90 mSv for 100 revolutions (90Sr/90Y irradiator
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Figure 1: Pictures of different instruments were used for the measurements.
calibration certificate). The Reader Calibration Factor (RCF) is the factor which converts
TL signal (i.e., current in nC) into dose and the RCF of the TLD reader was found to be
0.007 mSv/nC and the Elemental Correction Coefficient (ECC) is the property of a chip,
which is used to get the accurate radiation dose. Therefore, the individual TLD chips were
determined using the 90Sr/90Y irradiator. The RCF and ECC of the TLD reader and chips
respectively were determined using the measured 90Sr/90Y irradiator.
2.2 Phantom
It is seldom possible to measure dose distribution directly in patients treated with radiation.
Data on dose distribution are almost entirely derived from measurements in phantoms, tissue
equivalent materials, usually large enough in volume to provide full-scatter conditions for the
given beam (Fiaz, 1994). These basic data are used in a dose calculation system devised to
predict dose distribution in an actual patient.
In the present work, polystyrene slabs were used as a phantom material as shown in Fig.
1(c) where the phantom was on the couch of the X-ray unit. Precisely drilled holes on the
polystyrene sheet along the X-axis/Y-axis diverging from the end of the field area with the
dimension of 70 cm × 60 cm × 13 cm was used as the phantom. The variation of atomic
composition of commercially available polystyrene with the human body has been shown to
be small (Kase et al., 1983; Schulz et al., 1979). Therefore this material was employed in this
study as a phantom without a specific chemical analysis of their atomic composition.
2.3 Method of Calibration for TLD chips
For our present work, we used a 60Co teletherapy (ALCYON II, CGR, MeV, France) unit of
activity 223.6 TBq (on 09 June, 1994) as shown in Fig. 1(b) and a Deep therapy X-ray unit
(Siemens Ltd., Germany) as shown in Fig. 1(c).
In order to calibrate the TLD chips for a 60Co teletherapy unit, twenty-five (25) TLD
chips were divided into five groups having five chips in each group. These five groups were
irradiated by the 60Co teletherapy unit at a known dose of 101.55 mGy, 152.25 mGy, 203.1
mGy, 253.9 mGy and 304.65 mGy. The dosimetry of the 60Co unit was performed by us-
ing an ion chamber (PTW, UNIDOS, SI. No. N23323-3713, Vol. 0.3 cc) and electrometer
(PTW, UNIDOS, Germany, SI. No. 10005 - 50146) procured from PTB, Braunsech, Weig.,
Germany. These chips were read in the TLD reader applying the corresponding Element
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Figure 2: Calibration graphs (as well as equations) of average counts in a TLD reader to
known dose to TLD chips (in mGy).
Correction Coefficients (ECCs) and Reader Calibration Factors (RCFs). The calibration
curve after performing a least square fit of the plotted data following a procedure given in
(Gottfried, 1979) for 60Co teletherapy is shown in Fig. 2(a).
For Orthovoltage and Superficialvoltage Teletherapy (250 kVp, 120 kVp), fifty (50) field
dosimeters were divided into ten groups having five chips in each group. Five groups were
irradiated by 250 kVp X-ray at a known dose of 66.8 mGy, 133.5 mGy, 200.3 mGy, 267.1
mGy, and 333.8 mGy. Another five groups were irradiated by 120 kVp X-ray at a known
dose of 90.4 mGy, 135.6 mGy, 180.8 mGy, 226.0 mGy, 316.6 mGy. The dosimetry of the
orthovoltage and superficial voltage X-ray teletherapy were carried out by using a 0.6 cc
capintec ion chamber and Farmer electrometer. These chips were read in the TLD reader
applying the ECCs and RCF. The calibration curves after performing a least square fit of
the plotted data following a procedure given in (Gottfried, 1979) for orthovoltage (250 kVp)
and superficialvoltage (120 kVp) teletherapy are shown in Fig. 2(b) and 2(c) respectively.
More detailed data on the procedure of the calibration of the TLDs, as reported elesewhere
( Ahmed et al., 1999; Goil De Planque Burke, 1976; Hussain et al., 1982; Md. Farid Ahmed,
1994; Md. Farid Ahmed 2000; User’s Manual, 1993).
2.4 Calculation Method
Francois et al. (1988) derived a formula giving the dose on the X-axis/Y-axis of a rectangular
field with an elongation coefficient ecx/ecy on that axis, at a distance dx/dy from the edge
and at depth z in the tissue. The general expression of that dose is given by the following
equation:
Dri(eci, z, di) = Ds(z = 5, di)EFi(eci, di)DF (z, di), i = x, y (1)
where, Dri(eci, z, di) is the dose at distance di from the edge of the rectangular field (on the
axis) with an elongation coefficient eci and at depth z. Ds(z = 5, di) is the dose of the square
field (ec = 1) of equal area at the same distance (on the axis) at 5 cm depth. EFi(eci, di) is
an elongation factor depending upon the elongation coefficient eci of the rectangular field at
the distance di from the field edge on the i(x, y)-axis. DF (z, di) is a depth factor depending
upon the depth of calculation z at the distance di from the field edge.
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2.4.1 Elongation Factors (EF)
The Elongation factor EF (eci, di) is defined (Francois et al., 1988) as followis:
EFi(eci, di) =
Dri(eci, z = 5, di)
Ds(z = 5, di)
, i = x, y, (2)
where, Dri(eci, z = 5, di) is the dose at distance d from the edge of a rectangular field with
an elongation coefficient ec, at 5-cm depth. Ds(z = 5, di) is the dose at the same distance
and at the same depth for a square field of the same area.
2.4.2 Depth Factors (DF)
The Depth factor DF (z, di) is defined (Francois et al., 1988) as follows:
DF (z, d) =
Ds(z, d)
Ds(z = 5, d)
(3)
where, Ds(z, di) is the dose at distance di from the edge of a square field of surface at depth
z. Ds(z = 5, di) is the dose at the same distance from the same field at 5-cm depth.
2.5 Procedure for the Determination of Dose
In the present work, the previously selected seventy-five (75) TLD chips of LiF-100 known as
Field Dosimeters were of nearly the same ECCs (upper ECC limit 1.20 and lower 0.80) and
were used for the measurement of dose over the phantom throughout the experiment. The
ECC and identity of each chip was kept same throughout the experiment.
In order to measure the distribution of dose outside the radiation beam, field dosimeters
were distributed within precisely drilled holes on the polystyrene sheet along the X-axis/Y-
axis diverging from the end of the field area. In this study, the scattering doses were measured
at distances of 5 cm, 10, cm, 20 cm, 25 cm, 30 cm, 35 cm and 40 cm away from the end of
the treatment area along the axis of the field. The field sizes (15 cm × 15 cm); (10 cm × 10
cm) and (5 cm × 5 cm) were selected for 60Co and X-ray teletherapy units.
In the case of the elongation factor, dose distribution was measured with field sizes (5 cm ×
20 cm); (7.07 cm × 14.14 cm); (10 cm × 10 cm); (14.14 cm × 7.07 cm) and (20 cm × 5 cm),
for the 60Co unit in order to maintain the elongation coefficient (EC) 4, 2, 1, 0.5 and 0.25
respectively. The field sizes were defined at the surfaces of the phantom with the source to
surface distance (SSD) 80 cm. The points of interest for dose measurement were chosen at
different distances, such as, from 10 cm to 40 cm with 5 cm interval, from the edge of the
surface of the phantom.
The dose distribution was measured at depths of 1 cm, 5 cm, and 10 cm and field size
10 cm × 10 cm for the determination of the depth factor. The field sizes were defined at the
surface of the phantom. The locations of dose measurements were chosen as in the previous
set up.
The treatment area, i.e., desired field size, was irradiated by 500 cGy and the TLD chips,
which were irradiated by scattered radiation, were then read by the TLD reader and the dose
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data was calculated using corresponding calibration curve as shown in Fig. 2. The chips
were then annealed following standard procedure (400◦C for 1 hour and 100◦C for 2 hours)
and became ready for reuse. The overall measurements were conducted with the fields and
depths, which are usually adopted in treatment of cancer patients throughout Bangladesh.
The net counts of the TLD chips attributed to the exposure of scattered radiation due to
radiotherapy were obtained following the procedure, as reported elsewhere (Ahmed et al.,
1999; Ahmed, M. F., 1994; Ahmed, M. F., 2000; User’s Manual, 1993). These counts were
converted to dose in mGy employing the calibration graph in Fig. 2 represented by the least
square fitted equations.
3 RESULTS
The variation of dose at different distances with different square fields outside the beam for
60Co, 250 kVp X-rays, 120 kVp X-rays have been presented in Figs. 3 - 5. The given dose
at the square fields were 500 cGy for 60Co and 500 R for X-rays. Fig. 6 and Table 1
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Figure 3: Dose distribution outside the beam for a 60Co unit with 80 cm SSD and 500 cGy
given dose.
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Figure 4: Dose distribution outside the beam for the 250 kVp X-ray unit with 50 cm SSD, 1
mm Cu filter and 500 R given dose.
represent the measured dose distribution at different distance of the phantom due to 60Co
for different field shapes (but same field area) i.e., for different elongation coefficients. It
represents the variation of dose outside the beam with different elongation coefficients of a
field area 100 cm2. Based on our experience in fitting the data used in Figs. 3-5, the data
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Figure 5: Dose distribution outside the beam for the 120 kVp X-ray unit with 35 cm SSD, 4
mm Al filter and 500 R given dose.
of the Fig. 6 can be fitted closely to an exponential ”y = a × exp(−bx)”. Then using this
fitted exponential equation, the data were recalculoated for corresponding elongation factors
which are presented in Fig. 7.
Table 1: Measured dose (mSv) distribution at different distance of the phantom due
to radiotherapy (60Co teletherapy) for different field sizes (same field area).
[SSD: 80 cm; Given dose: 500 cGy; Depth: 5 cm]
Distance Dose for Dose for Dose for Dose for Dose for
(di) 5 × 20 7.07 × 14.14 10 × 10 14.14 × 7.07 20 × 5
(cm) (cm2) (cm2) (cm2) (cm2) (cm2)
10 58 ± 5 62 ± 2 64 ± 1 47 ± 9 40 ± 4
15 41 ± 3 33 ± 2 31 ± 2 27 ± 6 23 ± 4
20 27.5 ± 5.6 23 ± 1.6 19.8 ± 1.4 13.3 ± 1.6 11.5 ±1
25 19 ±9 16.4 ±0.8 12.6 ±2.1 9.4 ±0.7 8 ±1.3
30 13.2 ± 5.2 10.5 ±1.5 7.9 ±0.7 6.1 ±0.3 4 ± 0.2
35 8.3 ±1.7 6.2 ± 0.6 5.3 ± 0.2 3.7 ± 0.4 2.7 ± 0.04
40 5.2 ± 0.4 4 ± 0.7 3.3 ± 0.3 2.7 ± 0.5 2.1 ± 0.09
Table 2: Measured dose (mGy) distribution at different distance of the phantom due
to radiotherapy (60Co teletherapy) for different depths with 10 × 10 cm2
field size.
[SSD: 80 cm; Given dose: 500 cGy]
Distance Dose for Dose for Dose for
(di) (cm) depth 1 cm depth 5 cm depth 10 cm
10 55± 0 59± 1.6 45.95± 1.05
15 37±0.2 31.5 ±2.2 28.9± 2
20 29.3±0.9 22.2± 0.5 14.65± 0.25
25 20.7± 0 15.5± 0.2 8.5± 0.6
30 13.1± 0.5 10.05±0.15 5.9±0.4
35 8.55± 0.05 7.15± 0.65 4.2 ± 0
40 4.3±0.2 3.3±0.1 3± 0.1
7
 0
 10
 20
 30
 40
 50
 60
 70
 10  15  20  25  30  35  40
M
ea
su
re
d 
do
se
 in
 m
G
y 
fo
r 5
00
 c
G
y 
gi
ve
n 
do
se
Distance from the field edge (cm)
Fitted for EC(4):y=135exp(-0.0804x)
Measured data
(a) Field Size 5 cm × 20 cm
 0
 10
 20
 30
 40
 50
 60
 70
 10  15  20  25  30  35  40
M
ea
su
re
d 
do
se
 in
 m
G
y 
fo
r 5
00
 c
G
y 
gi
ve
n 
do
se
Distance from the field edge (cm)
Fitted for EC(2):y=116exp(-0.093x)
Measured data
(b) Field Size 7.07 cm × 14.14 cm
 0
 10
 20
 30
 40
 50
 60
 10  15  20  25  30  35  40
M
ea
su
re
d 
do
se
 in
 m
G
y 
fo
r 5
00
 c
G
y 
gi
ve
n 
do
se
Distance from the field edge (cm)
Fitted for EC(0.5):y=85exp(-0.103x)
Measured data
(c) Field Size 14.14 cm × 7.07 cm
 0
 5
 10
 15
 20
 25
 30
 35
 40
 45
 10  15  20  25  30  35  40
M
ea
su
re
d 
do
se
 in
 m
G
y 
fo
r 5
00
 c
G
y 
gi
ve
n 
do
se
Distance from the field edge (cm)
Fitted for EC(0.25):y=78exp(-0.105x)
Measured data
(d) Field Size 20 cm × 5 cm
Figure 6: Dose distribution outside the beam with different Elongation Coefficients (EC) [(a)
EC=4; (b) EC=2; (c) EC=0.5; (d) EC=0.25] of a 100 cm2 field area (rectangular fields) for
the 60Co unit with 80 cm SSD; 5 cm depth and 500 cGy given dose.
Fig. 8 and Tale 2 represent the variation of radiation dose outside the treatment area at
different depths with the field size (10 cm × 10 cm) for 60Co teletherapy. The data of Fig.
8 can be fitted closely to an exponential equation as ”y = a × exp(−bx)”. Using this fitted
exponential equation, the data were recalculated to calculate the depth factors which are
presented in Fig. 9.
Each point of interest in the phantom contained 2 TLD chips except during the study of
elongation factors, 3 chips were used to ensure a better accuracy for elongation factor.
4 DISCUSSIONS
Radiation outside the treatment field arises from scatter generated by the patient, treatment
couch, walls of the room and from leakage through the machine’s shielding and collimators,
which is known as secondary radiation. This secondary radiation is dependent on beam en-
ergy, field size, depth of measurement and distance from the field edge. Although there are
differences in machine design which can affect the total secondary radiation, the measure-
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Figure 7: Variation of Elongation Factors (EF) with different Elongation Coefficients (EC)
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ments represented here (Figs. 3 - 5 ) are in good agreement with those reported by other
authors (Ahmed et al., 1999; Fraass et al., 1983; Francois et al., 1988; Green et al., 1983;
Green et al., 1985; Kase et al., 1983; Miah et al., 1998).
As the field size increases, the fraction of dose contributed by phantom and wall scattered
photons at a given distance from the field edge increases, eventually the fraction of dose
collimator scatter and leakage decreases. So the total dose at any given point outside the
treatment area increases with increasing field size, but the differences become less at large
distances where collimator scatter and leakage dominate the dose. The variation of the dose
with the different field shapes is illustrated in Figs. (3 - 6). The most obvious feature of these
curves is the increase of the dose at a given distance from the field edge with the increase of
the field elongation coefficient. This can be explained by the variation of the different compo-
nents of the total secondary/scattered dose. Near the field, the scattered radiation from the
patient is predominant. As the distance from the field edge increases, the radiation scattered
by the collimator, the transmission through the collimator and the machine leakage become
dominant (Kase et al., 1983). The scattered radiation from the collimator is presumably
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Figure 8: Dose distribution outside the beam with different depths for a 10 cm × 10 cm
square field for the 60Co unit with 80 cm SSD and given dose 500 cGy.
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Figure 9: Variation of Depth Factors (DF) with distance (di) for a 10 cm × 10 cm square
field for the 60Co unit with 80 cm SSD.
coming from the face of the beam-defining jaw seen from the point of measurement. For this
reason, the scatter contribution from the jaw at this point will increase with the irradiation
area of that jaw. In the case of rectangular field size (5 cm × 20 cm), there is a ratio of
four between the edges of the field and eventually the increase of areas of the two pairs of
defining jaws. It could explain the differences between doses at equal distance from the field
edge on the two axes (Francois et al., 1988). Close to the field edge, the isodose curve has an
elliptical shape which follows approximately the shape of the field (Francois et al., 1988). If
the distance increases further, the isodose line becomes elliptic again but with the two axes
inverted (Francois et al., 1988). In fact, the isodose is not really elliptical in the area where
the beam-defining jaws cross, because there is a double attenuation through the collimator
jaws. The elongation factor (EF) at a given distances increases as the elongation coefficient
(EC) increases. Figs. 6 and 7 represent the expected result, which are in good agreement
with Francois et al., (1988).
The dose decreases with the depth for distances from the field edge (Fig. 8). Due to scarcity
of the facilities, the depth could not be made more than 10 cm for the determination of the
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depth factor. Close to the field edge, where scatter from the patient dominates, the total
secondary dose increases with depth because the ratio of the scatter-to-primary increases
with depth (Francois et al., 1988). Away from the field edge, where collimator scatter and
leakage dominate, the total secondary dose decreases with depth because of attenuation in
tissues beyond the depth of the maximum dose. Again as the depth increases, the depth
factor at a given distance decreases (Fig. 9). Figs. 8 - 9 are representing the expected result,
which are in good agreement with Francois et al. 1988.
A few general comments may be made. Due to the manual method of measurements, there
are some minimum differences of the readings. However, it may be observed in the Tables
that, the measured dose in mGy for each distance of the phantom were quite consistent
providing confidence in the present measurements.
5 CONCLUSIONS
The 1980 BEIR Committee report (National Academy of Sciences, 1980) published the data
for estimation of the excess risks of producing secondary tumors among long-term survivors.
If a 30 year-old male received 1 Gy to one of his lungs, the estimated excess risk for develop-
ing lung cancer within his remaining expected lifetime of 40.5 yr would be approximately 1
percent (Kase et al., 1983). So, the measurement of scattered radiation outside the treatment
area is important for the long lived survivors.
Although of considerable uncertainty, our interest is to estimate the risk to patients from
a dose outside the treatment field, and the possible benefits of diminishing that dose. The
dose distribution measured over different distance from the end of the treatment area of the
phantom during radiotherapy is the first reported measurement of this type in Bangladesh.
The data reported in this paper are believed to be quite accurate. The data so obtained may
be employed to compute doses in the underlying tissue of the whole body and the other inter-
nal radiosensitive organs, viz. lens of the eye, thyroid, oesophagus, stomach, cervix, kidney,
gonad, bone marrow etc., and recommend measures for their protection. This is, in fact, the
central objective of the radiological practice. Such protective measures may be taken and
in turn, the cancer patients can have relatively better health as long as they survive which
is also one of the major objectives of the technological advances in the present day medical
treatment.
An estimated incidence of new cancer cases in Bangladesh is about 200,000 per year and
an annual death rate is about 150,000 (Huq et al., 1992). This situation definitely warrants
improvement and expansion of the facilities, like treatment planning, study of scattered dose,
etc. No reported data in this connection was found in Bangladesh so far. These experiments
are generally conducted by an Anderson phantom in developed countries. But for developing
countries, it is very difficult to procure such an expensive phantom. So, this experiment was
conducted by using the locally fabricated phantom made of polystyrene sheets.
These type of measurement could be extended to other radiotherapy centres globally where
expensive Anderson phantoms are unavailable.
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